Abstract
T lymphocytes are stimulated when they recognize short peptides bound to class I proteins of the major histocompatibility complex (MHC) protein, as peptide–MHC complexes. Due to the diversity in T-cell receptor (TCR) molecules together with both the peptides and MHC proteins they bind to, it has been difficult to design vaccines and treatments based on these interactions. Machine learning has made some progress in trying to predict the immunogenicity of peptide sequences in the context of specific MHC class I alleles but, as such approaches cannot integrate temporal information and lack explanatory power, their scope will always be limited. Here, we advocate a mechanistic description of antigen presentation and TCR activation which is explanatory, predictive, and quantitative, drawing on modeling approaches that collectively span several length and time scales, being capable of furnishing reliable biological descriptions that are difficult for experimentalists to provide. It is a form of multiscale systems biology. We propose the use of chemical rate equations to describe the time evolution of the foreign and host proteins to explain how the original proteins end up being presented on the cell surface as peptide fragments, while we invoke molecular dynamics to describe the key binding processes on the molecular level, including those of peptide–MHC complexes with TCRs which lie at the heart of the immune response. On each level, complementary methods based on machine learning are available, and we discuss the relationship between these divergent approaches. The pursuit of predictive mechanistic modeling approaches requires experimentalists to adapt their work so as to acquire, store, and expose data that can be used to verify and validate such models.
Highlights
The immune system’s ability to fight against pathogens such as viruses and bacteria varies between individuals and is influenced by an area of the human genome known as the major histocompatibility complex (MHC)
Once in the endoplasmic reticulum (ER), peptides may be loaded on to MHC class I (MHCI) molecules, which are transported through the Golgi apparatus to the cell surface
The cell surface pMHC complexes bind with T-cell receptors (TCRs), initiating a signal cascade resulting in T-cell activation and the killing of target cells. pMHC affinity to TCR [2] and cell surface peptide abundance are correlated with T-cell immunodominance [3], the dominant clonal expansion of T-cells that respond to specific peptides, or epitopes
Summary
The immune system’s ability to fight against pathogens such as viruses and bacteria varies between individuals and is influenced by an area of the human genome known as the major histocompatibility complex (MHC). Several epitope prediction algorithms have been produced using machine learning methods, such as the MHC peptide processing tool from the immune epitope database (IEDB) [5] This algorithm is built upon datasets of in vitro experiments characterizing proteasomal cleavage rates, TAP affinity, and MHC binding of thousands of different peptides, combining the three metrics to produce a total “score” for each possible peptide from an input protein amino acid sequence. Machine learning algorithms are thought to be able to predict the efficiency of peptide processing for MHC presentation accurately when comparing peptides originating from a single protein Their predictions provide a static view of immunogenicity based upon sequence-specificity; they cannot account for protein abundance kinetics, which has a substantial impact on the hierarchy of peptide abundance at the cell surface [4]. Possible to include machine learning methods within mechanistic pathway prediction models by incorporating sequence-specific distinctions between peptides via their kinetic behavior
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.